This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lehman, T. A. Articles by Harris, C. C. Search for Related Content PubMed PubMed Citation Articles by Lehman, T. A. Articles by Harris, C. C.

p53 Mutations, ras Mutations, and p53-Heat Shock 70 Protein Complexes in Human Lung Carcinoma Cell Lines

Laboratories of Human Carcinogenesis [T. A. L., W. P. B., R. A. M., J. A. W., J. E., R. V. M., B. I. G., C. C. H.] and Cell Biology [S. U., J. W. R., E. A.], National Cancer Institute, NIH, Bethesda, Maryland 20892, and Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [J. R. T.]

The p53 tumor suppressor gene is frequently mutated and the K-ras oncogene is occasionally mutated in primary specimens of human lung carcinomas. These mutated genes also cooperate in the immortalization and neoplastic transformation of rodent cells. To determine whether these mutations are necessary for maintenance of the immortalized and/or neoplastically transformed states of human bronchial epithelial cells, the p53 gene and regions of the ras (K-, H-, and N-) genes were sequenced in nine human lung carcinoma cell lines. Detection of p53 mutations by polymerase chain amplification and direct DNA sequencing was corroborated by p53 immunocytochemistry and coimmunoprecipitation of p53 with heat shock protein 70. p53 and ras genes were frequently, but not always, mutated in the carcinoma cell lines. These data are consistent with the hypothesis that multiple genetic changes involving both protooncogenes and tumor suppressor genes occur during lung carcinogenesis.

¹ To whom requests for reprints should be addressed, at Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Building 37, Room 2C05, Bethesda, MD 20892.

Received 4/ 3/91. Accepted 6/14/91.

This article has been cited by other articles:

				P. P. Gan, E. Pasquier, and M. Kavallaris Class III {beta}-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non Small Cell Lung Cancer Cancer Res., October 1, 2007; 67(19): 9356 - 9363. [Abstract] [Full Text] [PDF]

				A. Panner, J. C. Murray, M. S. Berger, and R. O. Pieper Heat Shock Protein 90{alpha} Recruits FLIPS to the Death-Inducing Signaling Complex and Contributes to TRAIL Resistance in Human Glioma Cancer Res., October 1, 2007; 67(19): 9482 - 9489. [Abstract] [Full Text] [PDF]

				H. Sutterluty, C.-E. Mayer, U. Setinek, J. Attems, S. Ovtcharov, M. Mikula, W. Mikulits, M. Micksche, and W. Berger Down-Regulation of Sprouty2 in Non-Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms Mol. Cancer Res., May 1, 2007; 5(5): 509 - 520. [Abstract] [Full Text] [PDF]

				J. L. Woo and A. J. Berk Adenovirus Ubiquitin-Protein Ligase Stimulates Viral Late mRNA Nuclear Export J. Virol., January 15, 2007; 81(2): 575 - 587. [Abstract] [Full Text] [PDF]

				J Peltonen, J A Welsh, and K H Vahakangas Is there a role for PCR-SSCP among the methods for missense mutation detection of TP53 gene? Human and Experimental Toxicology, January 1, 2007; 26(1): 9 - 18. [Abstract] [PDF]

				S Kruger, A Bier, C Engel, E Mangold, C Pagenstecher, M von Knebel Doeberitz, E Holinski-Feder, G Moeslein, K Schulmann, J Plaschke, et al. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC) J. Med. Genet., October 1, 2005; 42(10): 769 - 773. [Abstract] [Full Text] [PDF]

				A. Masuda, K. Maeno, T. Nakagawa, H. Saito, and T. Takahashi Association between Mitotic Spindle Checkpoint Impairment and Susceptibility to the Induction of Apoptosis by Anti-Microtubule Agents in Human Lung Cancers Am. J. Pathol., September 1, 2003; 163(3): 1109 - 1116. [Abstract] [Full Text] [PDF]

				K. Ookawa, T. Kudo, S. Aizawa, H. Saito, and S. Tsuchida Transcriptional Activation of the MUC2 Gene by p53 J. Biol. Chem., December 6, 2002; 277(50): 48270 - 48275. [Abstract] [Full Text] [PDF]

				T. Fujita, M. Maruyama, J. Araya, K. Sassa, Y. Kawagishi, R. Hayashi, S. Matsui, T. Kashii, N. Yamashita, E. Sugiyama, et al. Hydrogen Peroxide Induces Upregulation of Fas in Human Airway Epithelial Cells via the Activation of PARP-p53 Pathway Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 542 - 552. [Abstract] [Full Text] [PDF]

				J. D. Hunt, A. Strimas, J. E. Martin, M. Eyer, M. Haddican, B. G. Luckett, B. Ruiz, T. W. Axelrad, W. L. Backes, and E. T. H. Fontham Differences in KRAS Mutation Spectrum in Lung Cancer Cases between African Americans and Caucasians after Occupational or Environmental Exposure to Known Carcinogens Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1405 - 1412. [Abstract] [Full Text] [PDF]

				V. W. van Beusechem, P. B. van den Doel, J. Grill, H. M. Pinedo, and W. R. Gerritsen Conditionally Replicative Adenovirus Expressing p53 Exhibits Enhanced Oncolytic Potency Cancer Res., November 1, 2002; 62(21): 6165 - 6171. [Abstract] [Full Text] [PDF]

				S. T. Cheung, X. Chen, X. Y. Guan, S. Y. Wong, L. S. Tai, I. O. L. Ng, S. So, and S. T. Fan Identify Metastasis-associated Genes in Hepatocellular Carcinoma through Clonality Delineation for Multinodular Tumor Cancer Res., August 15, 2002; 62(16): 4711 - 4721. [Abstract] [Full Text] [PDF]

				N.J. Hodges and J.K. Chipman Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells Carcinogenesis, January 1, 2002; 23(1): 55 - 60. [Abstract] [Full Text] [PDF]

				N.J. Hodges, B. Adam, A.J. Lee, H.J. Cross, and J.K. Chipman Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability Mutagenesis, November 1, 2001; 16(6): 467 - 474. [Abstract] [Full Text] [PDF]

				D. M. DeMarini, S. Landi, D. Tian, N. M. Hanley, X. Li, F. Hu, B. C. Roop, M. J. Mass, P. Keohavong, W. Gao, et al. Lung Tumor KRAS and TP53 Mutations in Nonsmokers Reflect Exposure to PAH-Rich Coal Combustion Emissions Cancer Res., September 1, 2001; 61(18): 6679 - 6681. [Abstract] [Full Text] [PDF]

				A. Yamashita, T. Ohnishi, I. Kashima, Y. Taya, and S. Ohno Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay Genes & Dev., September 1, 2001; 15(17): 2215 - 2228. [Abstract] [Full Text] [PDF]

				K. H. Vahakangas, W. P. Bennett, K. Castren, J. A. Welsh, M. A. Khan, B. Blomeke, M. C. R. Alavanja, and C. C. Harris p53 and K-ras Mutations in Lung Cancers from Former and Never-Smoking Women Cancer Res., June 1, 2001; 61(11): 4350 - 4356. [Abstract] [Full Text] [PDF]

				F. Biramijamal, A. Allameh, P. Mirbod, H.-J. Groene, R. Koomagi, and M. Hollstein Unusual Profile and High Prevalence of p53 Mutations in Esophageal Squamous Cell Carcinomas from Northern Iran Cancer Res., April 1, 2001; 61(7): 3119 - 3123. [Abstract] [Full Text]

				J. H. Schiller, S. Adak, R. H. Feins, S. M. Keller, W. A. Fry, R. B. Livingston, M. E. M. Hammond, B. Wolf, L. Sabatini, J. Jett, et al. Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non-Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy J. Clin. Oncol., January 15, 2001; 19(2): 448 - 457. [Abstract] [Full Text] [PDF]

				O. Wildner and J. C. Morris The Role of the E1B 55 kDa Gene Product in Oncolytic Adenoviral Vectors Expressing Herpes Simplex Virus-tk: Assessment of Antitumor Efficacy and Toxicity Cancer Res., August 1, 2000; 60(15): 4167 - 4174. [Abstract] [Full Text]

				B. R. Dix, S. J. O’Carroll, C. J. Myers, S. J. Edwards, and A. W. Braithwaite Efficient Induction of Cell Death by Adenoviruses Requires Binding of E1B55k and p53 Cancer Res., May 1, 2000; 60(10): 2666 - 2672. [Abstract] [Full Text]

				J.-W. Chang, Y.-C. Chen, C.-Y. Chen, J.-T. Chen, S.-K. Chen, and Y.-C. Wang Correlation of Genetic Instability with Mismatch Repair Protein Expression and p53 Mutations in Non-Small Cell Lung Cancer Clin. Cancer Res., May 1, 2000; 6(5): 1639 - 1646. [Abstract] [Full Text]

				T. A. Lehman, B. G. Haffty, C. J. Carbone, L. R. Bishop, A. A. Gumbs, S. Krishnan, P. G. Shields, R. Modali, and B. C. Turner Elevated Frequency and Functional Activity of a Specific Germ-Line p53 Intron Mutation in Familial Breast Cancer Cancer Res., February 1, 2000; 60(4): 1062 - 1069. [Abstract] [Full Text]

				G. D. Kirk, A.-M. Camus-Randon, M. Mendy, J. J. Goedert, P. Merle, C. Trepo, C. Brechot, P. Hainaut, and R. Montesano Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia J Natl Cancer Inst, January 19, 2000; 92(2): 148 - 153. [Abstract] [Full Text] [PDF]

				D. Kandioler-Eckersberger, C. Ludwig, M. Rudas, S. Kappel, E. Janschek, C. Wenzel, H. Schlagbauer-Wadl, M. Mittlböck, M. Gnant, G. Steger, et al. TP53 Mutation and p53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients Clin. Cancer Res., January 1, 2000; 6(1): 50 - 56. [Abstract] [Full Text]

				A. F. Soriano, B. Helfrich, D. C. Chan, L. E. Heasley, P. A. Bunn Jr., and T.-C. Chou Synergistic Effects of New Chemopreventive Agents and Conventional Cytotoxic Agents against Human Lung Cancer Cell Lines Cancer Res., December 1, 1999; 59(24): 6178 - 6184. [Abstract] [Full Text] [PDF]

				G. I. Shapiro, D. A. Koestner, C. B. Matranga, and B. J. Rollins Flavopiridol Induces Cell Cycle Arrest and p53-independent Apoptosis in Non-Small Cell Lung Cancer Cell Lines Clin. Cancer Res., October 1, 1999; 5(10): 2925 - 2938. [Abstract] [Full Text] [PDF]

				D. Rajesh, K. Schell, and A. K. Verma Ras Mutation, Irrespective of Cell Type and p53 Status, Determines a Cell's Destiny to Undergo Apoptosis by Okadaic Acid, an Inhibitor of Protein Phosphatase 1 and 2A Mol. Pharmacol., September 1, 1999; 56(3): 515 - 525. [Abstract] [Full Text]

				M. C. Tammemagi, J. R. McLaughlin, and S. B. Bull Meta-Analyses of p53 Tumor Suppressor Gene Alterations and Clinicopathological Features in Resected Lung Cancers Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 625 - 634. [Abstract] [Full Text]

				J. N. Harada and A. J. Berk p53-Independent and -Dependent Requirements for E1B-55K in Adenovirus Type 5 Replication J. Virol., July 1, 1999; 73(7): 5333 - 5344. [Abstract] [Full Text]

				D. Kandioler-Eckersberger, S. Kappel, M. Mittlbock, G. Dekan, C. Ludwig, E. Janschek, R. Pirker, E. Wolner, and F. Eckersberger THE TP53 GENOTYPE BUT NOT IMMUNOHISTOCHEMICAL RESULT IS PREDICTIVE OF RESPONSE TO CISPLATIN-BASED NEOADJUVANT THERAPY IN STAGE III NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 744 - 750. [Abstract] [Full Text] [PDF]

				A. S. Turnell, R. J. A. Grand, and P. H. Gallimore The Replicative Capacities of Large E1B-Null Group A and Group C Adenoviruses Are Independent of Host Cell p53 Status J. Virol., March 1, 1999; 73(3): 2074 - 2083. [Abstract] [Full Text]

				S. Ambs, W. P. Bennett, W. G. Merriam, M. O. Ogunfusika, S. M. Oser, A. M. Harrington, P. G. Shields, E. Felley-Bosco, S. P. Hussain, and C. C. Harris Relationship Between p53 Mutations and Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer J Natl Cancer Inst, January 6, 1999; 91(1): 86 - 88. [Full Text] [PDF]

				Y.-C. Wang, C.-Y. Chen, S.-K. Chen, Y.-Y. Chang, and P. Lin p53 Codon 72 Polymorphism in Taiwanese Lung Cancer Patients: Association with Lung Cancer Susceptibility and Prognosis Clin. Cancer Res., January 1, 1999; 5(1): 129 - 134. [Abstract] [Full Text] [PDF]

				F. D. Goodrum and D. A. Ornelles p53 Status Does Not Determine Outcome of E1B 55-Kilodalton Mutant Adenovirus Lytic Infection J. Virol., December 1, 1998; 72(12): 9479 - 9490. [Abstract] [Full Text] [PDF]

				H. Adachi, G. Preston, B. Harvat, M. I. Dawson, and A. M. Jetten Inhibition of Cell Proliferation and Induction of Apoptosis by the Retinoid AHPN in Human Lung Carcinoma Cells Am. J. Respir. Cell Mol. Biol., March 1, 1998; 18(3): 323 - 333. [Abstract] [Full Text]

				J. A. Welsh, K. Castren, and K. H. Vahakangas Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls Clin. Chem., December 1, 1997; 43(12): 2251 - 2255. [Abstract] [Full Text] [PDF]

				J.-K. Hwang and C.-T. Lin Co-localization of Endogenous and Exogenous p53 Proteins in Nasopharyngeal Carcinoma Cells J. Histochem. Cytochem., July 1, 1997; 45(7): 991 - 1004. [Abstract] [Full Text]

				T. Naka, Y. Iwamoto, N. Shinohara, H. Chuman, and M. Tsuneyoshi p53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases International Journal of Surgical Pathology, July 1, 1997; 5(1-2): 1 - 9. [Abstract] [PDF]

				A. Inoue, T. Torigoe, K. Sogahata, K. Kamiguchi, S. Takahashi, Y. Sawada, M. Saijo, Y. Taya, S.-i. Ishii, N. Sato, et al. 70-kDa Heat Shock Cognate Protein Interacts Directly with the N-terminal Region of the Retinoblastoma Gene Product pRb J. Biol. Chem., September 22, 1995; 270(38): 22571 - 22576. [Abstract] [Full Text] [PDF]

				E Speir, R Modali, E. Huang, M. Leon, F Shawl, T Finkel, and S. Epstein Potential role of human cytomegalovirus and p53 interaction in coronary restenosis Science, July 15, 1994; 265(5170): 391 - 394. [Abstract] [PDF]

				F Aguilar, C. Harris, T Sun, M Hollstein, and P Cerutti Geographic variation of p53 mutational profile in nonmalignant human liver Science, May 27, 1994; 264(5163): 1317 - 1319. [Abstract] [PDF]

				D. Kandioler, M. Foedinger, M. R. Mueller, F. Eckersberger, C. Mannhalter, and E. Wolner Carcinogen-specific mutations in the p53 tumor suppressor gene in lung cancer J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1095 - 1098. [Abstract] [Full Text]

				P. F. Bongiorno, R. I. Whyte, E. J. Lesser, J. H. Moore, M. B. Orringer, and D. G. Beer Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 590 - 595. [Abstract] [Full Text]

				C. C. Harris and M. Hollstein Clinical Implications of the p53 Tumor-Suppressor Gene N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327. [Full Text]

				D J Phillips, J M Benson, J M Pruckler, and W C Hooper PCR regimen for enhanced specificity and yield of targeted genomic DNA sequences: ras and p53. Genome Res., August 1, 1992; 2(1): 45 - 50. [Abstract] [PDF]

				D M Harvey and A J Levine p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes & Dev., December 1, 1991; 5(12b): 2375 - 2385. [Abstract] [PDF]